Zawaneh MS, Stambler BS. Chronic Suppression of Ventricular Tachyarrhythmias in Patients with ICDs.
Card Electrophysiol Clin 2010;
2:443-457. [PMID:
28770802 DOI:
10.1016/j.ccep.2010.06.008]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
In this review, we examine the data evaluating the role of adjuvant therapy with antiarrthymic drugs (AADs) in chronic suppression of ventricular tachyarrhythmias in the patient with an ICD. It must be noted that all uses of AADs for this indication represent "off-label" prescription. No AAD is approved by the Food and Drug Administration (FDA) specifically as a therapy to reduce ICD shocks.
Collapse